[1]
P. Kaur, X. Jiang, and E. Stier, “Analysis of Non-Pivotal Bioequivalence Studies Submitted in Abbreviated New Drug Submissions for Delayed-Release Drug Products”, J Pharm Pharm Sci, vol. 20, pp. 252–257, Jul. 2017.